Ozempic
What it is
Ozempic is a brand name for semaglutide, a once-weekly injectable GLP-1 receptor agonist made by Novo Nordisk. It mimics the GLP-1 hormone the body releases after eating, which can slow digestion and reduce appetite.
What it's used for
FDA-approved to improve blood sugar control in adults with type 2 diabetes, and to reduce the risk of major cardiovascular events in adults with type 2 diabetes and known heart disease. It is widely discussed for weight management, though that specific indication is approved under the Wegovy brand.
Typical dosing schedule
Dosing schedules differ by person and are set by a prescriber. The pattern below is a commonly described escalation — it is informational only, not a recommendation.
| Dose | Typical timing | Notes |
|---|---|---|
| 0.25 mg | Weeks 1–4 | Starting dose to help the body adjust; not intended for blood-sugar control. |
| 0.5 mg | Weeks 5–8 | First therapeutic dose. |
| 1.0 mg | Weeks 9+ | Increase if more control is needed and tolerated. |
| 2.0 mg | As directed | Maximum dose for some patients. |
Common side effects
Commonly reported side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, and fatigue, often most noticeable after a dose increase. Many people find symptoms ease over time, but persistent or severe symptoms should always be discussed with your prescriber. See our side-effects guide for management tips members commonly share.
Rough cost
Roughly $900–$1,100/month at US list price without insurance; coverage and manufacturer savings cards can lower this substantially.
Pricing varies widely. See our cost & insurance guide for savings programs, prior-authorization basics, and more.
Discuss it with the community
Read real member experiences and ask questions: